Today's Research Daily features new research reports on 12 major stocks, including AbbVie Inc. (ABBV), Lockheed Martin ...
Alvotech (NASDAQ:ALVOW – Get Free Report) was the recipient of a large growth in short interest during the month of February. As of February 28th, there was short interest totalling 9,400 shares, a ...
The bioengineered protein drugs market is experiencing a paradigm shift, with pharmaceutical and biotech companies leveraging advanced biopharmaceuti ...
The NHS saved nearly £99.4 million by using Infliximab, the biosimilar version of Jannssen’s Remicade and £60 million by switching from Amgen/Pfizer’s Enbrel to Etanercept.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results